Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.

Cai S, Hong TS, Goldberg SI, Fernandez-del Castillo C, Thayer SP, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Willett CG, Lillemoe KD, Warshaw AL, Wo JY.

Cancer. 2013 Dec 1;119(23):4196-204. doi: 10.1002/cncr.28329. Epub 2013 Sep 4.

2.

Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study.

Vainshtein JM, Schipper M, Zalupski MM, Lawrence TS, Abrams R, Francis IR, Khan G, Leslie W, Ben-Josef E.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):96-101. doi: 10.1016/j.ijrobp.2012.11.020. Epub 2012 Dec 19.

3.

Long-term results of intraoperative electron beam radiation therapy for nonmetastatic locally advanced pancreatic cancer: Retrospective cohort study, 7-year experience with 247 patients at the National Cancer Center in China.

Chen Y, Che X, Zhang J, Huang H, Zhao D, Tian Y, Li Y, Feng Q, Zhang Z, Jiang Q, Zhang S, Tang X, Huang X, Chu Y, Zhang J, Sun Y, Zhang Y, Wang C.

Medicine (Baltimore). 2016 Sep;95(38):e4861. doi: 10.1097/MD.0000000000004861.

4.

External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.

Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K, Hiraoka M, Ohshio G, Imamura M, Takahashi M, Abe M.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):39-49.

PMID:
9300738
5.

Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancer.

Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A, Yamada S, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakao A.

Pancreatology. 2011;11(1):68-75. doi: 10.1159/000324682. Epub 2011 Apr 27.

PMID:
21525774
6.

Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.

O'Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1060-6. Epub 2005 Jun 22.

PMID:
15978737
7.

Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.

Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J.

Cancer. 2017 Sep 15;123(18):3486-3493. doi: 10.1002/cncr.30706. Epub 2017 May 10.

8.

Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma.

Bachireddy P, Tseng D, Horoschak M, Chang DT, Koong AC, Kapp DS, Tran PT.

Radiat Oncol. 2010 Nov 8;5:105. doi: 10.1186/1748-717X-5-105.

9.

Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.

Furuse J, Kinoshita T, Kawashima M, Ishii H, Nagase M, Konishi M, Nakagohri T, Inoue K, Ogino T, Ikeda H, Maru Y, Yoshino M.

Cancer. 2003 Mar 1;97(5):1346-52.

10.

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302.

PMID:
11955742
11.

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer.

Ma SJ, Prezzano KM, Hermann GM, Singh AK.

Radiat Oncol. 2018 Nov 6;13(1):214. doi: 10.1186/s13014-018-1158-z.

12.

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.

Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH.

Cancer. 2006 Dec 1;107(11):2589-96.

13.

Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer.

Yang SH, Guo JC, Yeh KH, Tien YW, Cheng AL, Kuo SH.

J Gastroenterol Hepatol. 2016 Dec;31(12):2004-2012. doi: 10.1111/jgh.13395.

PMID:
27059987
14.

Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.

Schuricht AL, Spitz F, Barbot D, Rosato F.

Am Surg. 1998 Nov;64(11):1043-9.

PMID:
9798766
15.

External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer.

Roldan GE, Gunderson LL, Nagorney DM, Martin JK, Ilstrup DM, Holbrook MA, Kvols LK, McIlrath DC.

Cancer. 1988 Mar 15;61(6):1110-6.

PMID:
3342371
16.

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.

Peixoto RD, Speers C, McGahan CE, Renouf DJ, Schaeffer DF, Kennecke HF.

Cancer Med. 2015 Aug;4(8):1171-7. doi: 10.1002/cam4.459. Epub 2015 Apr 18.

17.

Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.

Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrel J, Hyslop T, Xu X, Berger AC.

Ann Surg Oncol. 2009 Aug;16(8):2116-22. doi: 10.1245/s10434-009-0498-1. Epub 2009 May 13.

PMID:
19437078
18.

Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.

Mellon EA, Hoffe SE, Springett GM, Frakes JM, Strom TJ, Hodul PJ, Malafa MP, Chuong MD, Shridhar R.

Acta Oncol. 2015 Jul;54(7):979-85. doi: 10.3109/0284186X.2015.1004367. Epub 2015 Mar 3.

PMID:
25734581
19.

Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan.

Jingu K, Tanabe T, Nemoto K, Ariga H, Umezawa R, Ogawa Y, Takeda K, Koto M, Sugawara T, Kubozono M, Shimizu E, Abe K, Yamada S.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e507-11. doi: 10.1016/j.ijrobp.2012.01.024. Epub 2012 Mar 22.

PMID:
22445002
20.

Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients.

Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers.

Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):734-42. doi: 10.1016/j.ijrobp.2009.09.010. Epub 2010 Mar 6.

PMID:
20207498

Supplemental Content

Support Center